StreetInsider.com News Articles

ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York

Wed, 27 May 2026 16:30:00 -0400

SAN DIEGO, May 27, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today announced that chief executive officer Kristin Yarema, Ph.D., will present at the Jefferies Global Healthcare Conference in New York on June 4, 2026 and management will participate in one-on-one meetings.

Jefferies Global Healthcare Conference in New York
Date: Thursday, June 4, 2026
Time: 12:50 PM EDT
Webcast: Linked here and archived for 90 days on events page on the Imagene IR website

About ImageneBio, Inc.
Imagene is a clinical-stage biotechnology company

ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York

Wed, 27 May 2026 16:30:00 -0400

Jefferies Global Healthcare Conference in New York
Date: Thursday, June 4, 2026
Time: 12:50 PM EDT
Webcast: Linked here and archived for 90 days on events page on the Imagene IR website

About ImageneBio, Inc.
Imagene is a clinical-stage biotechnology company

Form SCHEDULE 13G/A ImageneBio, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P

Fri, 15 May 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260515/26505614.html

Form SCHEDULE 13G/A ImageneBio, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P

Fri, 15 May 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260515/26505614.html

Form SCHEDULE 13G/A ImageneBio, Inc. Filed by: Blue Owl Capital Holdings LP

Thu, 14 May 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260514/26495311.html

Form SCHEDULE 13G/A ImageneBio, Inc. Filed by: Blue Owl Capital Holdings LP

Thu, 14 May 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260514/26495311.html

Form 424B3 ImageneBio, Inc.

Fri, 08 May 2026 06:07:00 -0400

si-local-file:///var/storage/secattach/20260508/26456931.html

Form 424B3 ImageneBio, Inc.

Fri, 08 May 2026 06:07:00 -0400

si-local-file:///var/storage/secattach/20260508/26456931.html

Form 424B3 ImageneBio, Inc.

Thu, 07 May 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20260507/26455319.html

Form 424B3 ImageneBio, Inc.

Thu, 07 May 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20260507/26455319.html

Form 10-Q ImageneBio, Inc. For: Mar 31

Thu, 07 May 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260507/26454054.html

Form 10-Q ImageneBio, Inc. For: Mar 31

Thu, 07 May 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260507/26454054.html

Form 8-K ImageneBio, Inc. For: May 07

Thu, 07 May 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260507/26453458.html

Form 8-K ImageneBio, Inc. For: May 07

Thu, 07 May 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260507/26453458.html

ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update

Thu, 07 May 2026 16:05:00 -0400

SAN DIEGO, May 07, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) ("Imagene" or the "Company") today reported financial results for the quarter ended March 31, 2026, and provided an update for its lead program, IMG-007, a non-T cell-depleting, ADCC-silenced anti-OX40 receptor antagonist with an extended half-life.

Company Highlights

In April 2026, the Company completed a private placement for gross proceeds of approximately $30 million led by new investor, Coastlands Capital, with participation from Trails Edge Capital Partners and existing investors Omega Funds and OrbiMed, among others. The financing extends the Company's cash

ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update

Thu, 07 May 2026 16:05:00 -0400

Company Highlights

In April 2026, the Company completed a private placement for gross proceeds of approximately $30 million led by new investor, Coastlands Capital, with participation from Trails Edge Capital Partners and existing investors Omega Funds and OrbiMed, among others. The financing extends the Company's cash

Form DEFA14A ImageneBio, Inc.

Thu, 30 Apr 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260430/26409133.html

Form DEFA14A ImageneBio, Inc.

Thu, 30 Apr 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260430/26409133.html

Form ARS ImageneBio, Inc. For: Dec 31

Thu, 30 Apr 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260430/26409157.html

Form ARS ImageneBio, Inc. For: Dec 31

Thu, 30 Apr 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260430/26409157.html

Form DEF 14A ImageneBio, Inc. For: Jun 16

Thu, 30 Apr 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260430/26409036.html

Form DEF 14A ImageneBio, Inc. For: Jun 16

Thu, 30 Apr 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260430/26409036.html

Form SCHEDULE 13D/A ImageneBio, Inc. Filed by: ORBIMED ADVISORS LLC

Wed, 29 Apr 2026 19:07:00 -0400

si-local-file:///var/storage/secattach/20260429/26397673.html

Form SCHEDULE 13D/A ImageneBio, Inc. Filed by: ORBIMED ADVISORS LLC

Wed, 29 Apr 2026 19:07:00 -0400

si-local-file:///var/storage/secattach/20260429/26397673.html

Form SCHEDULE 13G ImageneBio, Inc. Filed by: Trails Edge Capital Partners, LP

Tue, 21 Apr 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260421/26344695.html